[go: up one dir, main page]

ES548004A0 - Un procedimiento para producir un derivado de difenilmetilimina - Google Patents

Un procedimiento para producir un derivado de difenilmetilimina

Info

Publication number
ES548004A0
ES548004A0 ES548004A ES548004A ES548004A0 ES 548004 A0 ES548004 A0 ES 548004A0 ES 548004 A ES548004 A ES 548004A ES 548004 A ES548004 A ES 548004A ES 548004 A0 ES548004 A0 ES 548004A0
Authority
ES
Spain
Prior art keywords
group
sup
compound
salt
methylimine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548004A
Other languages
English (en)
Other versions
ES8609219A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Teikoku Hormone Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Manufacturing Co Ltd filed Critical Teikoku Hormone Manufacturing Co Ltd
Publication of ES8609219A1 publication Critical patent/ES8609219A1/es
Publication of ES548004A0 publication Critical patent/ES548004A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/50Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES548004A 1984-10-19 1985-10-18 Un procedimiento para producir un derivado de difenilmetilimina Expired ES8609219A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59218679A JPS61100555A (ja) 1984-10-19 1984-10-19 ベンゾフエノンオキシム誘導体

Publications (2)

Publication Number Publication Date
ES8609219A1 ES8609219A1 (es) 1986-09-01
ES548004A0 true ES548004A0 (es) 1986-09-01

Family

ID=16723718

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548004A Expired ES8609219A1 (es) 1984-10-19 1985-10-18 Un procedimiento para producir un derivado de difenilmetilimina

Country Status (10)

Country Link
US (1) US4673692A (es)
EP (1) EP0185158B1 (es)
JP (1) JPS61100555A (es)
KR (1) KR910002372B1 (es)
AT (1) ATE32216T1 (es)
AU (1) AU578979B2 (es)
CA (1) CA1253871A (es)
DE (1) DE3561512D1 (es)
ES (1) ES8609219A1 (es)
NZ (1) NZ213780A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6284051A (ja) * 1985-10-07 1987-04-17 Teikoku Hormone Mfg Co Ltd ジフエニルメチルイミン誘導体
EP0496434B1 (en) * 1987-10-22 1999-02-03 The Procter & Gamble Company Photoprotection compositions comprising chelating agents
WO1990011619A1 (en) * 1989-03-23 1990-10-04 Grumman Aerospace Corporation Single trench mosfet-capacitor cell for analog signal processing
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
WO1994005276A1 (en) * 1992-09-08 1994-03-17 Morgan Lee R Cytotoxic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925472A (en) * 1968-03-01 1975-12-09 Gen Mills Chem Inc Phenolic oximes
US4124725A (en) * 1977-05-16 1978-11-07 Riker Laboratories, Inc. Anti-inflammatory method
US4472435A (en) * 1980-07-31 1984-09-18 Hoffman-La Roche Inc. Benzophenone derivatives useful in treating heart failure
FR2540107B1 (fr) * 1983-01-28 1986-10-17 Inst Rech Chim Biolog Nouveaux derives d'halogenobenzophenone-oxime, utilisation en therapeutique et procede de preparation

Also Published As

Publication number Publication date
DE3561512D1 (de) 1988-03-03
AU4847185A (en) 1986-04-24
NZ213780A (en) 1989-08-29
EP0185158B1 (en) 1988-01-27
JPS61100555A (ja) 1986-05-19
EP0185158A1 (en) 1986-06-25
ES8609219A1 (es) 1986-09-01
KR860003204A (ko) 1986-05-21
ATE32216T1 (de) 1988-02-15
JPH0477742B2 (es) 1992-12-09
KR910002372B1 (ko) 1991-04-20
US4673692A (en) 1987-06-16
AU578979B2 (en) 1988-11-10
CA1253871A (en) 1989-05-09

Similar Documents

Publication Publication Date Title
ES557199A0 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
MD960212A (en) Acylfulvene analogs as antitumor remedy
ES8802014A1 (es) Un procedimiento para la preparacion de derivados de ariletanolamina.
ES8609204A1 (es) Procedimiento de preparar derivados aminicos
ES2043830T3 (es) Un metodo para preparar un compuesto de bis-(metilenodioxi)bifenilo.
ES8502099A1 (es) Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
MY109628A (en) An improved proces for the preparation of substituted indoline derivatives
NO915049L (no) Indenoindolforbindelser ii
ES548004A0 (es) Un procedimiento para producir un derivado de difenilmetilimina
FR2540870B1 (es)
MX158073A (es) Procedimiento para preparar dipropilamino-2-hidroxi-6-formilamino-5-o-tetrahidro-1,2-3,4,-naftaleno
ES553207A0 (es) Un procedimiento para la preparacion de una octahidroindolizina
AU6826887A (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
DE3572814D1 (en) 1, 3-benzoxathiole derivatives, their use and their preparation
DE3164005D1 (en) Use of alpha-azolylglycoles as plant growth regulators
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
ES550781A0 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
ES8201525A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,1'-bifenil-2-il-alquilamina
ES8302008A1 (es) Un procedimiento para la preparacion de derivados de imidazo (2,1-b) tiazol.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.